Canandaigua National Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.35M | Buy |
+23,502
| New | +$1.35M | 0.11% | 156 |
|
|
2025
Q4 | $1.37M | Sell |
25,448
-4,766
| -16% | -$229K | 0.12% | 151 |
|
|
2025
Q3 | $1.36M | Sell |
30,214
-1,529
| -5% | -$71.4K | 0.12% | 164 |
|
|
2025
Q2 | $1.47M | Sell |
31,743
-6,151
| -16% | -$302K | 0.14% | 146 |
|
|
2025
Q1 | $2.31M | Sell |
37,894
-2,043
| -5% | -$119K | 0.23% | 99 |
|
|
2024
Q4 | $2.26M | Sell |
39,937
-2,345
| -6% | -$131K | 0.22% | 102 |
|
|
2024
Q3 | $2.19M | Sell |
42,282
-2,952
| -7% | -$138K | 0.21% | 112 |
|
|
2024
Q2 | $1.88M | Sell |
45,234
-7,048
| -13% | -$315K | 0.2% | 111 |
|
|
2024
Q1 | $2.84M | Sell |
52,282
-3,535
| -6% | -$180K | 0.42% | 71 |
|
|
2023
Q4 | $2.86M | Sell |
55,817
-8,998
| -14% | -$472K | 0.44% | 64 |
|
|
2023
Q3 | $3.76M | Buy |
64,815
+249
| +0.4% | +$15.3K | 0.61% | 42 |
|
|
2023
Q2 | $4.13M | Sell |
64,566
-649
| -1% | -$43.5K | 0.67% | 38 |
|
|
2023
Q1 | $4.52M | Buy |
+65,215
| New | +$4.6M | 0.76% | 35 |
|
|
2020
Q1 | $4.6M | Buy |
82,503
+4,938
| +6% | +$302K | 0.97% | 28 |
|
|
2019
Q4 | $4.98M | Buy |
77,565
+14,264
| +23% | +$817K | 0.84% | 33 |
|
|
2019
Q3 | $3.21M | Buy |
63,301
+2,322
| +4% | +$109K | 0.57% | 54 |
|
|
2019
Q2 | $2.77M | Buy |
60,979
+3,772
| +7% | +$176K | 0.51% | 56 |
|
|
2019
Q1 | $2.73M | Buy |
57,207
+2,868
| +5% | +$143K | 0.52% | 55 |
|
|
2018
Q4 | $2.83M | Sell |
54,339
-2,478
| -4% | -$133K | 0.6% | 52 |
|
|
2018
Q3 | $3.53M | Sell |
56,817
-716
| -1% | -$42.5K | 0.63% | 45 |
|
|
2018
Q2 | $3.18M | Buy |
57,533
+964
| +2% | +$52.1K | 0.61% | 46 |
|
|
2018
Q1 | $3.58M | Buy |
56,569
+995
| +2% | +$64K | 0.46% | 59 |
|
|
2017
Q4 | $3.41M | Sell |
55,574
-1,505
| -3% | -$94.1K | 0.61% | 45 |
|
|
2017
Q3 | $3.64M | Sell |
57,079
-14
| -0% | -$817 | 0.69% | 41 |
|
|
2017
Q2 | $3.18M | Sell |
57,093
-1,873
| -3% | -$102K | 0.65% | 44 |
|
|
2017
Q1 | $3.21M | Sell |
58,966
-2,972
| -5% | -$163K | 0.95% | 31 |
|
|
2016
Q4 | $3.62M | Sell |
61,938
-19
| -0% | -$1.04K | 1.09% | 26 |
|
|
2016
Q3 | $3.34M | Sell |
61,957
-856
| -1% | -$55K | 0.97% | 30 |
|
|
2016
Q2 | $4.62M | Sell |
62,813
-3,819
| -6% | -$270K | 1.31% | 22 |
|
|
2016
Q1 | $4.26M | Buy |
66,632
+2,975
| +5% | +$188K | 1.25% | 24 |
|
|
2015
Q4 | $4.38M | Sell |
63,657
-290
| -0.5% | -$19.2K | 1.34% | 20 |
|
|
2015
Q3 | $3.79M | Sell |
63,947
-1,131
| -2% | -$71.7K | 1.21% | 23 |
|
|
2015
Q2 | $4.33M | Buy |
65,078
+2,975
| +5% | +$196K | 1.27% | 21 |
|
|
2015
Q1 | $4.01M | Sell |
62,103
-827
| -1% | -$51.8K | 1.2% | 24 |
|
|
2014
Q4 | $3.71M | Sell |
62,930
-775
| -1% | -$43.7K | 1.18% | 21 |
|
|
2014
Q3 | $3.26M | Buy |
63,705
+1,173
| +2% | +$58.6K | 1.08% | 25 |
|
|
2014
Q2 | $3.03M | Buy |
62,532
+168
| +0.3% | +$8.28K | 1.01% | 29 |
|
|
2014
Q1 | $3.24M | Sell |
62,364
-4,495
| -7% | -$239K | 1.1% | 24 |
|
|
2013
Q4 | $3.55M | Sell |
66,859
-1,485
| -2% | -$75.6K | 1.25% | 19 |
|
|
2013
Q3 | $3.16M | Sell |
68,344
-2,330
| -3% | -$102K | 1.2% | 20 |
|
|
2013
Q2 | $3.16M | Buy |
+70,674
| New | +$3.07M | 1.24% | 21 |
|
Other funds holding BMY
AIM
FWIA
Canandaigua National Bank & Trust's BMY Position: Q2 2026 in Review
Canandaigua National Bank & Trust opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 23,502 shares worth $1.35M. The stake represents 0.11% of the portfolio and ranks #156 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in BMY as recently as Q4 2025.
Canandaigua National Bank & Trust first reported a position in BMY in Q2 2013 and has held it in 41 quarters since. The position peaked at $4.98M in Q4 2019. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Canandaigua National Bank & Trust held 23,502 shares of Bristol-Myers Squibb worth $1.35M as of Q2 2026.
- Bristol-Myers Squibb was a new Canandaigua National Bank & Trust position in Q2 2026.
- Bristol-Myers Squibb made up 0.11% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #156 holding.
- Canandaigua National Bank & Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 41 quarters since.
- Canandaigua National Bank & Trust's Bristol-Myers Squibb position peaked at $4.98M in Q4 2019.
- 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.